Cancer clock: does treatment timing matter?
NCT ID NCT07452601
Summary
This study is testing whether the time of day a patient receives immunotherapy affects how well it works for esophageal cancer. It will involve 90 patients with a specific type of esophageal cancer that can be surgically removed. Patients will receive a combination of immunotherapy and chemotherapy before surgery, with some groups getting infusions in the morning and others in the afternoon, to see if timing impacts tumor response.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL SQUAMOUS CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Tangdu Hospital Affiliated to the Fourth Military Medical University
Xi'an, Shannxi, 710038, China
Conditions
Explore the condition pages connected to this study.